What to look forward to in GaBI Journal, 2022, Issue 2

Author(s): Professor Philip D Walson, MD

The rate of successful development, regulatory approval and marketing of both new and follow-on biological treatments has continued to accelerate despite, and in some cases because of, a seemingly endless list of disturbing world events. This GaBI issue contains manuscripts discussing a variety of topics that are already or promise to be critical to maintaining […]

Read more →